- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03133442
Effect of Vestibular Stimulation on Sleep in Elderly
Descripción general del estudio
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Zurich, Suiza, 8092
- Sensory Motor Systems Lab
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Right handed
- Between 60 and 75 years of age
Exclusion Criteria:
- Diseases or lesions of the nervous system (acute or residual included neurological and psychiatric diseases)
- BMI < 19 or > 30 kg/m2
- Medication known to influence sleep [56]
- Cognitive Impairment (MoCA score < 26)
- Drug use and abuse
- Nicotine use (e.g. smoking)
- > 10 alcoholic drinks per week
- > 5 drinks or foods containing caffeine per day
- History of sleep disorder (Insomnia, sleep apnea (apnea-hypopnea index >5), nocturnal myoclonus (>5 periodic leg movements per hour of sleep))
- Irregular sleep-wake rhythm (e.g. shift working)
- Travelling across time zones less than 1 month ago
- Naps longer than 1h
- Sleep on an average night <6 hours or >8 hours
- Skin allergies or very sensitive skin
- Diseases of the vestibular system
- Signs of motion sickness based on questionnaire
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Baseline Nights
No vestibular stimulation is applied.
However, the sound of the moving bed will be played back to the participant at the right sound intensity level.
|
|
|
Experimental: Movement Nights
Vestibular stimulation, in the form of gentle rocking movements, is provided using the Somnomat V4 rocking bed.
Stimulation is provided for the entire 7 hours of the night from lights off to lights on.
The stimulation frequency is in the range of 0.1-0.3
Hz, with an amplitude in the range of 0.05 to 0.1m
|
Vestibular stimulation is provided using an innervated bed platform.
This robotic device consists of a standard single bed, mounted on a moving mechanism.
It was developed and produced by the ETH Zürich and approved for use in this study by Swissmedic.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Polysomnography
Periodo de tiempo: 4 nights of 7 hours each
|
Difference in sleep parameters between the second of two nights with intervention and the second of two nights without intervention, as recorded using polysomnography. The sleep stages will be scored visually on a 20-s epoch basis according to standard criteria [53]. This will allow us to compare sleep architecture of the participants in the two conditions, as well as a possible consecutive nights effect in the two movement nights. Parameters of specific interest are sleep onset latency, total sleep time, time spent in N1, N2 and N3 stages of NREM sleep and time spent in REM sleep. Furthermore, the EEG power density spectra will be analysed. Power in specific frequency bands will be calculated based on spectral analysis, the amount and density of sleep spindles and slow waves will be determined. |
4 nights of 7 hours each
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Memory performance
Periodo de tiempo: Recall moment in evening and morning (4 nights)
|
Difference in declarative memory performance between the second of two nights with intervention and the second of two nights without intervention.
During each experimental night a word-pair recall task will be performed 1h before going to bed and half an hour after waking up.
To assess declarative memory performance improvement, we will determine the difference between immediate and delayed recall.
Word-pair recall tasks are suitable to determine declarative memory performance in the context of sleep, as they are sensitive to effects of sleep.
|
Recall moment in evening and morning (4 nights)
|
|
Skin temperature
Periodo de tiempo: 4 nights of 7 hours each
|
The distal-proximal temperature gradient will be calculated, based on skin temperature measured using sensors placed on the chest and hands, to look for a relationship with sleep onset latency.
|
4 nights of 7 hours each
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Robert Riener, Prof., University of Zurich
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- SOMNOMAT V4
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Somnomat V4
-
Kaneka CorporationClinSearchDesconocidoMalformaciones arteriovenosas | Aneurisma | Fístula arterio-venosaAlemania, Bélgica
-
Contamac LtdHartwig Research CenterTerminado
-
Columbia UniversityRetiradoComplicaciones oncológicas
-
Assistance Publique Hopitaux De MarseilleAix Marseille Université; UMR 5203, InsermU1191, IGF, Montpellier; CRMBM-CEMEREMAún no reclutandoEpilepsia resistente a los medicamentos
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminadoCarcinoma de células escamosas de cabeza y cuello | Carcinoma de cabeza y cuelloEstados Unidos
-
Jonsson Comprehensive Cancer CenterVarian Medical SystemsReclutamientoCarcinoma recidivante de cabeza y cuello | Carcinoma de cabeza y cuello | Carcinoma metastásico de cabeza y cuello | Carcinoma localizado de cabeza y cuelloEstados Unidos